117 related articles for article (PubMed ID: 8081703)
1. Alteration in length of telomeric repeats in lung cancer.
Shirotani Y; Hiyama K; Ishioka S; Inyaku K; Awaya Y; Yonehara S; Yoshida Y; Inai K; Hiyama E; Hasegawa K
Lung Cancer; 1994 Jul; 11(1-2):29-41. PubMed ID: 8081703
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer.
Hirashima T; Komiya T; Nitta T; Takada Y; Kobayashi M; Masuda N; Matui K; Takada M; Kikui M; Yasumitu T; Ohno A; Nakagawa K; Fukuoka M; Kawase I
Anticancer Res; 2000; 20(3B):2181-7. PubMed ID: 10928174
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity in small-cell and non-small-cell lung cancers.
Hiyama K; Hiyama E; Ishioka S; Yamakido M; Inai K; Gazdar AF; Piatyszek MA; Shay JW
J Natl Cancer Inst; 1995 Jun; 87(12):895-902. PubMed ID: 7666478
[TBL] [Abstract][Full Text] [Related]
4. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
Lin X; Gu J; Lu C; Spitz MR; Wu X
Clin Cancer Res; 2006 Oct; 12(19):5720-5. PubMed ID: 17020976
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of alterations in telomeric repeat length in patients with pathological stage I-II non-small cell lung cancer].
Hirashima T; Komiya T; Nitta T; Kobayashi M; Kawase I
Nihon Rinsho; 1998 May; 56(5):1264-71. PubMed ID: 9613135
[TBL] [Abstract][Full Text] [Related]
6. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
Lantuejoul S; Soria JC; Morat L; Lorimier P; Moro-Sibilot D; Sabatier L; Brambilla C; Brambilla E
Clin Cancer Res; 2005 Mar; 11(5):2074-82. PubMed ID: 15756034
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing, but not allelic loss, of the FHIT gene increases with development of lung cancer.
Sato H; Hiyama K; Ishioka S; Maeda H; Yamakido M
Int J Oncol; 1999 Jul; 15(1):81-8. PubMed ID: 10375597
[TBL] [Abstract][Full Text] [Related]
8. Telomere length maintenance in aging and carcinogenesis.
Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F
Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of tumour DNA profile related to response to radiotherapy and survival in inoperable lung cancer.
Ojala A; Kallioniemi OP; Wigren T; Kallioniemi A; Mattila J; Lehtinen M; Koivula T
Acta Oncol; 1990; 29(8):983-8. PubMed ID: 2177611
[No Abstract] [Full Text] [Related]
10. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb.
Hiyama K; Ishioka S; Shirotani Y; Inai K; Hiyama E; Murakami I; Isobe T; Inamizu T; Yamakido M
Oncogene; 1995 Mar; 10(5):937-44. PubMed ID: 7898935
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic characterization of neuroendocrine lung cancer cell lines.
Lai SL; Brauch H; Knutsen T; Johnson BE; Nau MM; Mitsudomi T; Tsai CM; Whang-Peng J; Zbar B; Kaye FJ
Anticancer Res; 1995; 15(2):225-32. PubMed ID: 7762988
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
Hurr K; Kemp B; Silver SA; el-Naggar AK
Am J Pathol; 1996 Aug; 149(2):613-20. PubMed ID: 8701999
[TBL] [Abstract][Full Text] [Related]
13. Telomere length, telomeric proteins and DNA damage repair proteins are differentially expressed between primary lung tumors and their adrenal metastases.
Raynaud CM; Mercier O; Commo F; Dartevelle P; Gomez-Roca C; de Montpreville V; Sabatier L; Soria JC
Lung Cancer; 2009 Aug; 65(2):144-9. PubMed ID: 19091442
[TBL] [Abstract][Full Text] [Related]
14. Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status.
Fernández-Marcelo T; Gómez A; Pascua I; de Juan C; Head J; Hernando F; Jarabo JR; Calatayud J; Torres-García AJ; Iniesta P
J Exp Clin Cancer Res; 2015 Aug; 34(1):78. PubMed ID: 26250468
[TBL] [Abstract][Full Text] [Related]
15. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up].
Nagai S; Chiba W; Ikeda S; Matsumoto H; Fujimoto T; Ishida H; Wazawa H; Hanawa T; Yamashita N; Yasuda Y; Matsubara Y; Hatakenaka R; Funatsu T
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():130-4. PubMed ID: 8678555
[TBL] [Abstract][Full Text] [Related]
16. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas.
Butler MG; Dahir GA; Hedges LK; Juliao SF; Sciadini MF; Schwartz HS
Cancer Genet Cytogenet; 1995 Nov; 85(1):51-7. PubMed ID: 8536238
[TBL] [Abstract][Full Text] [Related]
18. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
Hsu CP; Ko JL; Shai SE; Lee LW
Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
[TBL] [Abstract][Full Text] [Related]
19. Analysis of telomeric repeats and telomerase activity in human colon carcinoma cells with gene amplification.
Bolzán AD; Páez GL; Bianchi MS; Bianchi NO
Cancer Genet Cytogenet; 2000 Jul; 120(2):166-70. PubMed ID: 10942811
[TBL] [Abstract][Full Text] [Related]
20. Allelotype and loss of heterozygosity around the L-myc gene locus in primary lung cancers.
Mendoza C; Sato H; Hiyama K; Ishioka S; Isobe T; Maeda H; Hiyama E; Inai K; Yamakido M
Lung Cancer; 2000 May; 28(2):117-25. PubMed ID: 10717329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
